Soleno Therapeutics (SLNO) Gains from Investment Securities (2013 - 2026)
Soleno Therapeutics (SLNO) reported Gains from Investment Securities of $835911.0 for Q1 2026, up 23119.75% year-over-year from N/an in Q1 2025, and up 216.58% on a QoQ basis from -$717000.0 in Q4 2025.
Soleno Therapeutics (SLNO) has 14 years of Gains from Investment Securities data on file, last reported at $835911.0 in Q1 2026.
- Quarterly Gains from Investment Securities rose 23119.75% year-over-year to $835911.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $835911.0 (up 23119.75% YoY) and the FY2025 annual result came in at $4.0 million, up 1.52% from the prior year.
- Gains from Investment Securities climbed to $835911.0 in Q1 2026 per SLNO's latest filing, from -$717000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $2.8 million in Q4 2024 and bottomed at -$717000.0 in Q4 2025.
- The 5-year median for Gains from Investment Securities is $111496.5 (2022), against an average of $408823.7.
- The widest annual swing landed in 2023, when Gains from Investment Securities tumbled 5600.0%; it then surged 108138.0% in 2024.
- Tracing SLNO's Gains from Investment Securities over 5 years: stood at $1000.0 in 2022, then plunged by 5600.0% to -$55000.0 in 2023, then soared by 5254.55% to $2.8 million in 2024, then plunged by 125.29% to -$717000.0 in 2025, then surged by 216.58% to $835911.0 in 2026.
- Per Business Quant, the three latest SLNO Gains from Investment Securities figures stand at $835911.0 (Q1 2026), -$717000.0 (Q4 2025), and $400000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 835,911.00 |
| Mar 31, 2026 | 835,911.00 |
| Dec 31, 2025 | -717,000.00 |
| Dec 31, 2025 | -717,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 3,600.00 |
| Mar 31, 2025 | 3,600.00 |
| Dec 31, 2024 | 2.84 Mn |
| Dec 31, 2024 | 2.84 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Jun 30, 2024 | 1.08 Mn |
| Dec 31, 2023 | -55,000.00 |
| Dec 31, 2023 | -55,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Dec 31, 2022 | 1,000.00 |
| Jun 30, 2022 | 219,310.00 |
| Jun 30, 2022 | 219,310.00 |
| Mar 31, 2022 | 3,683.00 |
| Mar 31, 2022 | 3,683.00 |
| Dec 31, 2021 | 461,000.00 |
| Dec 31, 2021 | 461,000.00 |
| Sep 30, 2021 | -112,000.00 |
| Sep 30, 2021 | -112,000.00 |
| Jun 30, 2021 | 708,750.00 |
| Jun 30, 2021 | 708,750.00 |
| Mar 31, 2021 | 3,938.00 |
| Mar 31, 2021 | 3,938.00 |
| Dec 31, 2020 | -11.65 Mn |
| Dec 31, 2020 | -11.65 Mn |
| Sep 30, 2020 | 689,000.00 |
| Sep 30, 2020 | 689,000.00 |
| Jun 30, 2020 | -3.81 Mn |
| Jun 30, 2020 | -3.81 Mn |
| Mar 31, 2020 | -3.41 Mn |
| Mar 31, 2020 | -3.41 Mn |
| Dec 31, 2019 | 6.94 Mn |
| Dec 31, 2019 | 6.94 Mn |
| Jun 30, 2019 | 4.27 Mn |
| Jun 30, 2019 | 4.27 Mn |
| Mar 31, 2019 | 21,415.00 |
| Mar 31, 2019 | 21,415.00 |
| Dec 31, 2018 | -1.60 Mn |
| Dec 31, 2018 | -1.60 Mn |
| Sep 30, 2018 | -1.54 Mn |
| Sep 30, 2018 | -1.54 Mn |
| Jun 30, 2018 | 3.26 Mn |
| Jun 30, 2018 | 3.26 Mn |
| Mar 31, 2018 | 82,000.00 |
| Mar 31, 2018 | 82,000.00 |
| Dec 31, 2017 | 490,000.00 |
| Dec 31, 2017 | 490,000.00 |
| Jun 30, 2017 | 610,755.00 |
| Jun 30, 2017 | 610,755.00 |
| Mar 31, 2017 | 12,000.00 |
| Mar 31, 2017 | 12,000.00 |
| Dec 31, 2016 | 274,506.00 |
| Dec 31, 2016 | 274,506.00 |
| Jun 30, 2016 | 11,000.00 |
| Jun 30, 2016 | 11,000.00 |
| Mar 31, 2016 | 19,000.00 |
| Mar 31, 2016 | 19,000.00 |
| Dec 31, 2015 | 2.70 Mn |
| Dec 31, 2015 | 2.70 Mn |
| Mar 31, 2015 | 500,000.00 |
| Mar 31, 2015 | 500,000.00 |
| Dec 31, 2014 | 8,000.00 |
| Dec 31, 2014 | 8,000.00 |
| Jun 30, 2014 | 238,000.00 |
| Jun 30, 2014 | 238,000.00 |
| Mar 31, 2014 | -246,000.00 |
| Mar 31, 2014 | -246,000.00 |
| Dec 31, 2013 | -80,446.00 |
| Dec 31, 2013 | -80,446.00 |